Impaired toll-like receptor 8 signaling in multiple sclerosis

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Johnson, Tory P ^a   Tyagi, Richa ^a   Patel, Karan ^a   Schiess, Nicoline ^b   Calabresi, Peter A ^b   Nath, Avindra ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene expression; Interleukin 12; Multiple sclerosis; TLR8; Toll like receptor

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 12P40; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INTERLEUKIN 12P40 GENE; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84879114672     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-74     Document Type: Article

References (18)

1. Friese MA, Fugger L. Pathogenic CD8(+) T cells in multiple sclerosis. Ann Neurol 2009, 66:132-141. 10.1002/ana.21744, 19743458.
2. Racke MK, Drew PD. Toll-like receptors in multiple sclerosis. Curr Top Microbiol Immunol 2009, 336:155-168. 10.1007/978-3-642-00549-7_9, 3064511, 19688333.
3. McMahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 2005, 11:335-339. 10.1038/nm1202, 15735651.
4. Gambuzza M, Licata N, Palella E, Celi D, Foti Cuzzola V, Italiano D, Marino S, Bramanti P. Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management. J Neuroimmunol 2011, 239:1-12. 10.1016/j.jneuroim.2011.08.010, 21889214.
5. Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity 2010, 32:305-315. 10.1016/j.immuni.2010.03.012, 20346772.
6. Okun E, Griffioen KJ, Mattson MP. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci 2011, 34:269-281. 10.1016/j.tins.2011.02.005, 3095763, 21419501.
7. Funderburg N, Luciano AA, Jiang W, Rodriguez B, Sieg SF, Lederman MM. Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS One 2008, 3:e1915. 10.1371/journal.pone.0001915, 2271052, 18382686.
8. Ensoli F, Fiorelli V, Lugaresi A, Farina D, De Cristofaro M, Collacchi B, Muratori DS, Scala E, Di Gioacchino M, Paganelli R, Aiuti F. Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors alpha and beta, and interferon gamma. Mult Scler 2002, 8:284-288. 10.1191/1352458502ms817oa, 12166497.
9. Obradovic D, Kataranovski M, Dincic E, Obradovic S, Colic M. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis. Vojnosanit Pregl 2012, 69:151-156. 10.2298/VSP1202151O, 22500369.
10. Fischer M, Ehlers M. Toll-like receptors in autoimmunity. Ann N Y Acad Sci 2008, 1143:21-34. 10.1196/annals.1443.012, 19076342.
11. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
12. Kouwenhoven M, Teleshova N, Ozenci V, Press R, Link H. Monocytes in multiple sclerosis: phenotype and cytokine profile. J Neuroimmunol 2001, 112:197-205. 10.1016/S0165-5728(00)00396-9, 11108949.
13. Unutmaz D, Pileri P, Abrignani S. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Exp Med 1994, 180:1159-1164. 10.1084/jem.180.3.1159, 2191658, 8064232.
14. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240. 10.1084/jem.20041257, 2212798, 15657292.
15. Segal BM, Shevach EM. IL-12 unmasks latent autoimmune disease in resistant mice. J Exp Med 1996, 184:771-775. 10.1084/jem.184.2.771, 2192714, 8786337.
16. Constantinescu CS, Wysocka M, Hilliard B, Ventura ES, Lavi E, Trinchieri G, Rostami A. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J Immunol 1998, 161:5097-5104.
17. Demaria O, Pagni PP, Traub S, de Gassart A, Branzk N, Murphy AJ, Valenzuela DM, Yancopoulos GD, Flavell RA, Alexopoulou L. TLR8 deficiency leads to autoimmunity in mice. J Clin Invest 2010, 120:3651-3662. 2947223, 20811154.
18. Zhang X, Jin J, Tang Y, Speer D, Sujkowska D, Markovic-Plese S. IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation. J Immunol 2009, 182:3928-3936. 10.4049/jimmunol.0802226, 19265172.